Patents by Inventor Daniel Bracher

Daniel Bracher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal preparation contacting a loratidine metabolite with antihistaminic activity
    Patent number: 6395297
    Abstract: A transdermal patch contains an active loratidine metabolite contained with polyacrylate polymer matrix. The transdermal patch provides pharmaceutically useful transdermal flux rates over time.
    Type: Grant
    Filed: May 17, 2000
    Date of Patent: May 28, 2002
    Assignee: Hexal AG
    Inventors: Karin Klokkers, Wilfried Fischer, Daniel Bracher
  • Transdermal preparation containing a loratidine metabolite with antihistaminic activity
    Patent number: 6165498
    Abstract: A transdermal patch contains an active loratidine metabolite contained with a polyacrylate polymer matrix. The transdermal patch provides pharmaceutically useful transdermal flux rates over time.
    Type: Grant
    Filed: March 23, 1998
    Date of Patent: December 26, 2000
    Assignee: Hexal AG
    Inventors: Karin Klokkers, Wilfried Fischer, Daniel Bracher
  • Transdermal therapeutic system (TTS) containing vitamin E for the treatment of drug dependency
    Patent number: 5989585
    Abstract: The invention relates to a transdermal therapeutic system (TTS) for the administration of active agents for substitution treatment of drug dependency or drug addiction.
    Type: Grant
    Filed: June 23, 1998
    Date of Patent: November 23, 1999
    Assignee: Hexal AG
    Inventor: Daniel Bracher
  • Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same
    Patent number: 5856359
    Abstract: Thyroxine containing pharmaceutical compositions with improved aqueous solubility, stability and enhanced membrane permeation have been prepared by formulating thyroxine with cyclodextrins. These thyroxine/cyclodextrin complexes can further be transformed into different dosage forms (oral tablets, injectables, transdermal patches, hydrogels, ointments, suppositories etc.) by employing known, common pharmaceutical additives.
    Type: Grant
    Filed: July 24, 1997
    Date of Patent: January 5, 1999
    Assignee: Hexal AG
    Inventors: Wilfried Fischer, Daniel Bracher
  • Device for the measurement of the size of an eye pupil
    Patent number: 4007980
    Abstract: A device for measuring the size of an eye pupil, particularly with non-cooperating patients, has a body which contacts the eye and carries on it an illuminating light source, a series of light detectors and an optical system for collecting the divergent light from the illuminating source and directing such light towards the iris of the eye. A stimulus light source can also be included for directing stimulus light through the pupil and onto the retina.
    Type: Grant
    Filed: August 19, 1975
    Date of Patent: February 15, 1977
    Inventors: Daniel Bracher, Walter Lotmar